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Synthetic lipopeptides activate superoxide-anion (02-) formation
in human neutrophils in a pertussis-toxin (PTX)-sensitive
manner, suggesting the involvement of G-proteins of the G,
family in the signal-transduction pathway. We compared G-
protein activation by lipopeptides and the chemotactic peptide
N-formylmethionyl-leucyl-phenylalanine (fMLP) in dibutyryl-
cyclic-AMP-differentiated HL-60 cells. The lipopeptide (2S)-2-
palmitoylamino-6-palmitoyloxymethyl-7-palmitoyloxyhepta-
noyl-SK4 (Pam3AhhSK4) and fMLP activated high-affinity
GTPase, i.e. the enzymic activity of G-protein a-subunits, in HL-
60 membranes in a time- and protein-dependent manner, but
they had no effect on Mg2+-ATPase and Na+/K+-ATPase.
Pam3AhhSK4 and fMLP increased Vmax of GTP hydrolysis.
Pam3AhhSK4 activated GTP hydrolysis with half-maximal and
maximal effects at about 2,uM and 10,uM respectively. Other
lipopeptides activated GTP hydrolysis as well. Lipopeptides were
less effective than fMLP to activate GTPase. In membranes from
PTX-treated cells, the stimulatory effects of lipopeptides and
INTRODUCTION
Human neutrophils play an important role in host defence
against bacterial infections and are activated by the bacterial
chemotactic peptide fMLP (for review see Rossi, 1986; Seifert
and Schultz, 1991). fMLP, after binding to specific heptahelical
membrane receptors, activates the PTX-sensitive G-proteins, Gi2
and G,3 (Gierschik et al., 1989; Offermanns et al., 1990). This
process leads to the activation of phospholipase C and of non-
selective cation channels (resulting in an increase in [Ca2+] ) and
of phospholipase D (resulting in PA formation) (Pai et al., 1988;
Bauldry et al., 1991; Kessels et al., 1991; Seifert et al., 1992a;
Krautwurst et al., 1992). Stimulation by fMLP of neutrophils
and differentiated HL-60 leukaemic cells cumulates in the ac-
tivation of the 02-forming NADPH oxidase (for review see
Rossi, 1986; Seifert and Schultz, 1991).
The outer cell wall of Gram-negative bacteria contains lipo-
protein (for review see Braun, 1975). Lipoprotein and synthetic
lipopeptides are effective activators of B-lymphocytes (Resch
and Bessler, 1981; Bessler et al., 1985). We have shown recently
that lipopeptides activate 02- formation in human neutrophils in
a PTX-sensitive manner, suggesting the involvement of G,-
proteins in the signal-transduction pathway (Seifert et al., 1990).
As there is no known heptahelical receptor for lipopeptides, and
as only lipopeptides bearing positive charges activate 02-
fMLP on GTPase were abolished. In N-ethylmaleimide-treated
membranes, the relative stimulatory effect of Pam3AhhSK4 on
GTP hydrolysis was enhanced, whereas that of fMLP was
diminished. fMLP and Pam3AhhSK4 activated GTPase in an
over-additive manner in N-ethylmaleimide-treated membranes.
Unlike fMLP, Pam3AhhSK4 did not enhance incorporation of
GTP azidoanilide into, and cholera-toxin-catalysed ADP-ribo-
sylation of G,-protein oc-subunits in, HL-60 membranes and did
not induce rises in cytosolic Ca2+ concentration. Pam3AhhSK4
and fMLP stimulated phosphatidic acid formation in a PTX-
sensitive manner. Pam3AhhSK4 itself did *not activate 02-
formation, but potentiated the stimulatory effects of fMLP. Our
data suggest that (i) lipopeptides activate the GTPase of G,-
proteins, (ii) lipopeptides and fMLP activate Gi-proteins
differently, (iii) lipopeptides stimulate phospholipase D via G,-
proteins, and (iv) phosphatidic acid formation is not sufficient
for activation of 02- formation.
formation, we put forward the hypothesis that lipopeptides
activate Ga-proteins directly, i.e. in a manner similar to that of
other cationic-amphiphilic peptides such as substance P and the
wasp venom mastoparan (Higashijima et al., 1988, 1990; Mousli
et al., 1990; Seifert et al., 1990; Tomita et al., 1991). However,
the cationic-amphiphilic lipopeptides Pam3CSK4 and
Pam3AdhSK4do not stimulate GTP hydrolysis by G-proteins in
HL-60 membranes (Seifert et al., 1992b). Additionally, we have
shown that lipopeptides, i.e. Pam3CSK4 and Pam3AhhSK4,
activate tyrosine phosphorylation in Bt2cAMP-differentiated
HL-60 cells (Offermanns et al., 1992). The latter finding prompted
us to examine the effects ofPam3AhhSK4 on G-protein activation
in membranes from Bt2cAMP-differentiated HL-60 cells and to
study its effects on [Ca2+]1, PA formation and 02- formation in
these cells.
MATERIALS AND METHODS
Materials
The lipopeptides Pam3AhhSK4 Pam3CSK4RPQASGVYMGN-
LTAQ and Pam3CSK4RPQASVYMNLTAQ were kindly pro-
vided by Dr. J. Metzger, Dr. K.-H. Wiesmiuller and Dr. G. Jung,
Institut fur Organische Chemie der Universitiit Tiibingen,
Germany. The lipopeptide Pam3CSK4YGGFL was kindly pro-
vided by Dr. C. Sakarellos, Department ofChemistry, University
Abbreviations used: Bt2cAMP, dibutyryl cAMP; [Ca2+]i, cytosolic Ca2+ concentration; CTX, cholera toxin; G,-proteins, family of highly similar
G-proteins (Gil-G3); fMLP, N-formyl-L-methionyl-L-leucyl-L-phenylalanine; NEM, N-ethylmaleimide; 02-, superoxide anion; PA, phosphatidic acid,
Pam3, N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]; Pam3Adh, (2S)-palmitoylamino-6,7-bis(palmitoyloxy)heptanoyl; Pam3Ahh, (2S)-palmitoyl-
amino-6-palmitoyloxymethyl-7-palmitoyloxyheptanoyl; PTX, pertussis toxin. Peptide chains linked to Pam3, Pam3Adh and Pam3Ahh are given in the
one-letter code.
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of Ioannina, Greece. PTX was from List Biological Laboratories
(Campbell, CA, U.S.A.). 1-0-[3H]Hexadecyl-2-acetyl-sn-glycero-
3-phosphocholine (60 Ci/mmol) was from Dupont/New Eng-
land Nuclear (Bad Homburg, Germany). NEM was from Sigma
Chemie (Deisenhofen, Germany). Stock solutions of lipopeptides
(1 mM each) and dilutions were prepared in distilled water and
stored at -20 'C. Sources ofother materials have been described
elsewhere (Ebel et al., 1976; Rosenthal et al., 1986; Seifert and
Schultz, 1987; Seifert et al., 1990, 1992a,b; Offermanns et al.,
1990, 1991; Krautwurst et al., 1992; Wenzel-Seifert and Seifert,
1993).
Cell culture and membrane preparatlon
HL-60 cells were grown in suspension culture at 37 'C and
were differentiated towards neutrophil-like cells with Bt2cAMP
(0.2 mM) for 48 h (Wenzel-Seifert and Seifert, 1993). For deter-
mination of the activities of high-affinity GTPase, Mg2+-ATPase
and Na+/K+-ATPase, and for photolabelling, HL-60 membranes
were prepared as described by Seifert and Schultz (1987). PTX
(100 ng/ml) or its carrier (control) was added to cell cultures
24 h before measurement of PA formation or membrane prep-
aration. Under these conditions, more than 95 % of G,-protein
a-subunits were ADP-ribosylated (results not shown).
GTPase assay
GTP hydrolysis was determined as described by Wenzel-Seifert
and Seifert (1993). Reaction mixtures (100 ,d) contained
membranes from Bt2cAMP-differentiated HL-60 cells (3.0-
7.0 ,ug of protein/tube), 0.5 1sM [y-32P]GTP (0.1 ,Ci/tube),
0.5 mM MgCl2, 0.1 mM EGTA, 0.1 mM ATP, 1 mM adenosine
5'-[Ly-imido]triphosphate, 5 mM phosphocreatine, 40 jug of
creatine kinase, 1 mM dithiothreitol and 0.2% (w/v) BSA in
50 mM triethanolamine/HCl, pH 7.4. Reaction mixtures con-
tained substances at various concentrations and were pre-
incubated for 3 min at 25 'C. Reactions were initiated by addition
of [y-32P]GTP and were conducted for 10-20 min, unless stated
otherwise. Low-affinity GTPase activity was determined in the
presence of 50 ,sM GTP and amounted to < 5% of total GTPase
activity.
Treatment of HL-60 membranes with NEM
HL-60 membranes were treated with NEM as described by
McLeish et al., (1989) with modifications. Briefly, membranes
(5.0,Cg of protein/tube) were incubated for 10 min in reaction
mixtures containing 0.1 mM NEM or solvent (control), 0.5,uM
[y-32P]GTP (0.1 sCi/tube), 0.5 mM MgCl2, 0.1 mM EGTA,
0.1 mM ATP, 1 mM adenosine 5'-[fi,y-imido]triphosphate,
5 mM phosphocreatine, 40 ,ug of creatine kinase and 0.2% BSA
in 50 mM triethanolamine/HCl, pH 7.4. Thereafter, dithiothrei-
tol (5 mM) was added, and reaction mixtures were incubated
for a further 10 min. The membranes were then used immediately
for the GTPase assay.
Mg -ATPase and Na+/K+-ATPase assays
The activities of Mg2+-ATPase and Na+/K+-ATPase in HL-60
membranes were determined as described by Ebel et al. (1976).
solvent (control), Pam3AhhSK4 (10,M) or fMLP (10,M). The
amount of Pi in supernatant fluids of reaction mixtures was
determined as described by Ames (1966).
Assay for photolabelling of membrane proteins
HL-60 membranes (50,Cg of protein in 60,ul) were incubated at
30 °C in a buffer consisting of 0.1 mM EDTA, 5 mM MgCl2,
1 mM benzamidine, 10,M GDP and 30 mM Hepes/NaOH,
pH 7.4. After exposure to various substances, samples were
incubated for another 3 min with 10 nM [a-32P]GTP azidoanilide
(1 uCi/tube). Stopping of reactions and irradiation of samples
were performed as described by Offermanns et al. (1990).
Assay for CTX-catalysed ADP-ribosylatIon of membrane proteins
HL-60 cells were homogenized by 20 passes through a 26-gauge
needle in a buffer consisting of 150 mM NaCl, 3 mM MgCl2,
1 mM EDTA, 1 mM dithiothreitol and 20 mM Hepes/NaOH,
pH 7.4. After centrifugation at 1000 g for 10 min at 4 °C, the
supernatant suspension was incubated for 60 min at 30 °C in the
above buffer supplemented with 1 mM guanosine 5'-[/Jy-
imido]triphosphate. Thereafter, the suspension was centrifuged
at 30000 g for 15 min at 4 'C. The pellet, referred to as
membranes, was dissolved in a buffer containing 1 mM EDTA
and 10 mM Tris/HCl, pH 7.4. CTX was activated by mixing
toxin stock solution (2 mg/ml) with an equal volume of 40 mM
dithiothreitol and subsequent incubation for 10 min at 30 'C.
Reaction mixtures (50 ul) contained 3,iM [32P]NAD' (5,c1Ci/
tube), 3 mM MgCl2, 1 mM ATP, 10 mM thymidine, 0.2%
BSA, 2 ,g of activated CTX and 0.1 M potassium phosphate,
pH 7.4, and various substances. After preincubation for 3 min,
reactions were initiated by addition of membranes from about
1 x 107 HL-60 cells. After incubation for 60 min at 30 °C,
reactions were terminated by addition of 20 mM Hepes/NaOH,
pH 7.4 (4 'C), and centrifugation at 12000 g for 10 min at 4 'C.
Assay for PA formation
PA formation was determined as described by Pai et al. (1988)
and Bourgoin and Grinstein (1992), with modifications. In brief,
HL-60 cells were centrifuged at 250 g for 10 min at 20 'C and
were suspended at 1 x 106 cells/ml in a buffer consisting of
125 mM NaCl, 0.7 mM MgCl2, 0.5 mM EGTA, 10 mM glucose,
0.1 % fatty-acid-free BSA and 25 mM Hepes/NaOH, pH 7.2.
Centrifugation was repeated. HL-60 cells were suspended at
2 x 107 cells/ml in the above buffer and incubated for 90 min at
37 'C in the presence of 10-15 fiCi/ml 1-0-[3H]hexadecyl-2-
acetyl-sn-glycero-3-phosphocholine. Thereafter, cells were di-
luted to 1 x 106 cells/ml in the above buffer and were centrifuged
at 250 g for 10 min at 20 'C. HL-60 cells [(0.5-1.0) x 10" cells in
100 fil] were incubated for 6 min at 37 'C in the presence of
1 mM CaCl2 and 1 fg/ml cytochalasin B. Cells were exposed to
solvent (control), Pam3AhhSK4 (10 fiM) or fMLP (IfM) for
15 min. Reactions were terminated by the addition of 500 ,l of
CHCl3/CH3OH/conc. HCl (400:200:1, by vol.). Phase sep-
aration was achieved by addition of 250 ,ul of water and 150 fl of
CHC13. The samples were centrifuged at 12000 g for 10 min at
4 'C. The upper phase was removed, and 400 ,ul of the organic
phase was dried under nitrogen at 30 'C. Lipids were dissolved
in 50 jl of CHC13 and spotted on t.l.c. plates (Whatman LK
6 D). Non-radioactive lipid standards were added, and the
plates were developed in a solvent system consisting of
CHCl3/CH3OH/acetic acid (13:3:3, by vol). Lipid standards
Reaction mixtures (100 ,1d) contained 6.0,ug of protein and were detected by exposure to iodine vapour, and the areas
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Fire 1 Time- and protein-dependence of high-affinity GTP hydrolyski In membranes from Bt2cAMP-dlfferentlated HL-60 cells
High-affinity GTP hydrolysis was determined as described in the Materials and methods section in the presence of Pam3AhhSK4 (10 jiM) (*), fMLP (10 jiM) (-), or water added instead of
stimulus (control) (-). (a) GTP hydrolysis as a function of time. Reactions were conducted for the indicated periods of time. Reaction mixtures contained 5.7 g of protein (main panel) and
6.2 jig of protein (inset). (b) GTP hydrolysis as a function of the amount of protein. Reaction mixtures contained the indicated amounts of protein, and reactions were conducted for 15 min.
The open circles indicate that at the designated incubation time and amount of protein no GTP was hydrolysed. The stimulatory effects of Pam3AhhSK4 on GTP hydrolysis were significant versus
control (P <0.05, Wilcoxon test) under all conditions studied.
corresponding to PA were scraped off after sublimation of
iodine. Lipids were eluted from the silica gel with 1 M
HC1/CH30H (1/1, v/v), and radioactivity was determined in a
liquid-scintillation counter.
Assay for 02- formatlon
2- formation was monitored at 550 nm by continuous measure-
ment of ferricytochrome c reduction inhibitable by superoxide
dismutase, by using an Uvikon 810 dual-beam spectrophotometer
(Kontron, Eching, Germany) (Seifert et al., 1990). Bt2cAMP-
differentiated HL-60 cells (2.5 x 106 cells in 500 ,ul) were incubated
for 3 min at 37 °C before addition of stimuli. The absolute
amounts of 2- generated within 10 min were calculated.
Miscellaneous
Protein was determined by the method of Lowry et al. (1951).
[y-32P]GTP was prepared as described by Walseth et al. (1991).
[c_-32P]GTP azidoanilide was prepared as described by
Offermanns et al. (1991). [32P]NAD was synthesized as described
by Cassel and Pfeuffer (1978). SDS/PAGE and autoradiography
were performed as described by Rosenthal et al. (1986). [Ca2+]J
was determined by using the fluorescent dye fura-2, as described
by Seifert et al. (1992a).
Data reproducibility
Data shown in Figures 1-3 and 5 and Tables 1-3 are the means
of assay quadruplicates. Unless shown, the S.D. values were
generally less than 5 % (GTP hydrolysis) and 10% (02-
formation) of the means. Similar results were obtained with at
least three different preparations of HL-60 membranes or intact
HL-60 cells. Basal GTP hydrolysis and the extent of GTPase
stimulation caused by fMLP and Pam3AhhSK4 (10 j/M each)
varied to some extent among different membrane preparations
from Bt2cAMP-differentiated HL-60 cells (see Figures 1-3 and
Tables 1 and 2). Similar findings have been documented for basal
and fMLP-stimulated GTP hydrolysis in membranes from
dimethyl sulphoxide-differentiated HL-60 cells (McLeish et al.,
1989). The autoradiographs shown in Figure 4 are representative
of at least three independent experiments.
RESULTS
First, the time- and protein-dependence of high-affinity GTP
hydrolysis in HL-60 membranes was studied. In the presence of
5.7 jig of protein per tube, Pam3AhhSK4 and fMLP (10,M
each) stimulated GTP hydrolysis in a linear manner for up to
30 min (Figure 1). Activation of GTPase by the lipopeptide and
fMLP occurred without measurable delay (see Figure la, inset).
At an incubation time of 15 min, basal, lipopeptide- and fMLP-
stimulated GTP hydrolyses were linear up to 10 jig of protein per
tube.
Figure 2 shows typical Lineweaver-Burk plots of basal,
Pam3AhhSK4- and fMLP-stimulated GTP hydrolyses in HL-60
membranes. TheKm ofbasal high-affinity GTPase in HL-60 mem-
branes was 0.45 +0.12,M (mean+ S.D., n = 6). This value
corresponds to the Km of high-affinity GTPase in human and
rabbit neutrophil membranes (Feltner et al., 1986; Kupper et al.,
1992). The lipopeptide and the formyl-peptide increased VmJ.. of
GTP hydrolysis in HL-60 membranes without affecting K,.
The influence ofPam.AhhSK4andfMLP on Mg2+-ATPase and
Na+/K+-ATPase was studied. The activities of these enzymes in
HL-60 membranes were 0.26 + 0.06 and 0.15 + 0.02 j#mol/min
per mg respectively. Pam3AhhSK4 and fMLP (10,M each) did
not alter these enzyme activities (results not shown).
Concentration/response curves for the stimulatory effects of
Pam3AhhSK4 and fMLP on high-affinity GTPase in HL-60
membranes are shown in Figure 3. Pam.AhhSK4 activated GTP
hydrolysis with an EC50 of about 2,M and a maximum at
10,uM. fMLP activated GTPase with an EC50 of 0.5 jiM and
a plateau at 30-100I M. The effectiveness of Pam3AhhSK4
(100,M) to activate GTPase was about 30% of that of fMLP
(100 jiM).
The effects of four lipopeptides (10 jiM each) on GTP hydro-
lysis were compared (see Figure 3, inset). Pam3CSK4RPQA-
SGVYMGNLTAQ contains the epitope of lymphocytic chorio-
meningitis virus nucleoprotein, RPQASGVYMGNLTAQ, used
for induction of cytotoxic T-lymphocytes in vivo (Schulz et al.,
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Table 1 Effect of PTX on high-affinity GTP hydrolysis in membranes from
Bt2cAMP-dlfferentlated HL-60 cells
Treatments with carrier (control) and PTX were performed as described in the Materials and
methods section. High-affinity GTPase activity in HL-60 membranes was determined as
described in the Materials and methods section. For determination of basal GTP hydrolysis,
water (solvent) was added instead of stimulus.
GTP hydrolysis (pmol/min per mg)
Stimulus Control PTX
Water (solvent)
fMLP (10 ,uM)
Pam3AhhSK4 (10 1sM)
26.0 + 0.5
61.4 + 2.1
35.2 + 1.0
15.4 + 0.7
14.8 + 0.5
15.5 + 0.6
Figure 2 KInetIc analysis of hgh-affinity GTP hydrolysis in membranes
from Bt2cAMP-dNfferentlated HL-60 cells
GTP hydrolysis was determined as described in the Materials and methods section with GTP
(0.07-1.0 1sM) in the presence of Pam3AhhSK4 (10 ,PM) (*), fMLP (10 ,uM) (M), or water
added instead of stimulus (control) (M). Lineweaver-Burk plots of typical experiments are
shown. The stimulatory effects of Pam3AhhSK4 on GTP hydrolysis were significant versus
control (P < 0.05, Wilcoxon test) under all conditions studied.
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Figure 3 ConcentratIon/respons curves for effects of Pam,AhhSK and
fMLP on high-affinity GTP hydrolysis In membranes from Bt24MP-
dMifrentiated HL-60 elis: comparlson of effcts of various llpopeptides
High-affinity GTPase activity in HL-60 membranes was determined as described in the Materials
and methods section. Main panel: effects of Pam3AhhSK4 (*) and fMLP (U) at various
concentrations on GTP hydrolysis. Inset shows effects of various lipopeptides (10 1sM
each) on GTP hydrolysis: Pam3AhhSK4 (LP1), Pam3CSK4RPOASVYMNLTAQ (LP2),
Pam3CSK4RPQASGVYMGNLTAQ (LP3), Pam3CSK4YGGFL (LP4).
1991). The peptide RPQASVYMNLTAQ, contained in
Pam3CSK4RPQASVYMNLTAQ, lacks two glycine residues and
was prepared as control substance for induction of cytotoxic T-
lymphocytes (Schulz et al., 1991). Pam3CSK4YGGFL contains
the Leu-enkephalin pentapeptide, YGGFL. Pam3CSK4RPQ-
ASGVYMGNLTAQ and PamsCSK4RPQASVYMNLTAQ
Table 2 Effect of NEM on high-affinity GTP hydrolysis in membranes from
Bt2cAMP-dlfferentiated HL-60 cells: interactIon of PamAhhSK4 with fMLP
Treatments with solvent (control) and NEM were performed as described in the Materials and
methods section. High-affinity GTPase activity in HL-60 membranes was determined as
described in the Materials and methods section. For determination of basal GTP hydrolysis,
water (solvent) was added instead of stimulus.
GTP hydrolysis (pmol/min per mg)
Stimulus Control NEM
Water (solvent)
fMLP (10,uM)
Pam3AhhSK4 (10 1M)
fMLP + Pam3AhhSK4
12.8 + 0.2
21.4 + 0.8
17.0 + 0.5
23.3 + 0.4
6.5 + 0.1
9.1 +0.2
9.5+ 0.2
13.3 + 0.4
were similarly effective as Pam3AhhSK4 to stimulate GTPase,
whereas Pam3CSK4YGGFL was by about 50% less effective.
Table 1 compares the effects of Pam3AhhSK4 and fMLP on
GTP hydrolysis in control membranes and in membranes from
PTX-treated cells. In membranes from PTX-treated cells, the
stimulatory effects offMLP and Pam3AhhSK4 on GTP hydrolysis
were abolished. Similarly to Pam.AhhSK4. Pam CSK4RPQ-
ASGVYMGNLTAQ, Pam3CSK4RPQASVYMNLTAQ and
Pam3CSK4YGGFL (10 uM each) had no effect on GTP
hydrolysis in membranes from PTX-treated cells (results not
shown).
NEM alkylates G,-protein a-subunits, thereby uncoupling
receptors from G-proteins in a manner similar to that of PTX
(Jakobs et al., 1982; McLeish et al., 1989). In control and NEM-
treated membranes, fMLP stimulated GTPase by 67 % and
40% respectively (Table 2). The corresponding values for
Pam3AhhSK4 were 33 % and 46% respectively. In control
membranes, Pam3AhhSK4and fMLP activated GTP hydrolysis
in a sub-additive manner (82% stimulation), and in NEM-
treated membranes they interacted in an over-additive manner
(105% stimulation).
In addition to the determination of GTP hydrolysis,
photolabelling with the reactive GTP analogue GTP azidoanilide
is an established method to assess activation of G1-protein a-
subunits by formyl-peptide receptors. As reported for membranes
from dimethyl sulphoxide-differentiated HL-60 cells (Offermanns
et al., 1990), fMLP (10 M) increased incorporation of GTP
azidoanilide into 40/41 kDa proteins, corresponding to the a-
subunits of Gi2 and GI3, in membranes from Bt2cAMP-
differentiated HL-60 cells, but Pam3AhhSK4 (10 M) had no
stimulatory effect (Figure 4).
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Figure 5 Effects of Pam,AhhSK on 02- formation In Bt2cAMP-dlfferentlated
HL-60 cells: synergism with fMLP
02- formation was determined as described in the Materials and methods section. (a) Cells
were exposed to Pam3AhhSK4 at various concentrations in the presence of fMLP (1 ,M) (U)
or water instead of fMLP (*). (b) Cells were exposed to fMLP at various concentrations in
the presence of Pam3AhhSK4 (10 FM) (*) or water instead of Pam3AhhSK4 (-).
Figure 4 Effects of Pam3AhhSK4 and fMLP on incorporafon of GTP
azidoanhlide Into, and CTX-catalysed ADP-rlbosylation of G,-proteln ac-
subunits In membranes from Bt2cAMP-dlfferentlated HL-60 cells
(a) Photolabelling was performed as described in the Materials and methods section. The
autoradiogram of an SDS gel containing 4 M urea and 9% (w/v) acrylamide is shown. Lane
1, fMLP (10 1M); lane 2, water added instead of stimulus (control); lane 3, Pam3AhhSK4
(10 ,M). (b) ADP-ribosylation was performed as described in the Materials and methods section.
The autoradiogram of an SDS gel containing 10% (w/v) acrylamide is shown. Lane 1,
Pam3AhhSK4 (10 ,M); lane 2, water added instead of stimulus (control); lane 3, fMLP
(10 #M). Numbers on the left are molecular masses of marker proteins (kDa). DF, dye front.
Table 3 StUmulatlon by Pam,AhhSK4 and fMLP of PA formaffon in
Bt2cAMP-dlfferentlated HL-60 cells: effect of PTX
Treatments with carrier (control) and PTX were performed as described in the Materials and
methods section. PA formation was determined as described in the Materials and methods
section. The concentration of fMLP was 1 ,uM and that of Pam3AhhSK4 was 10,uM. For
determination of basal PA formation, water (solvent) was added instead of stimulus.
PA formation (d.p.m.)
Stimulus Control PTX
Water (solvent
fMLP
Pam3AhhSK4
652 + 36
924 + 66
799+ 33
458 +6
492 +27
497 +21
Moreover, CTX-catalysed ADP-ribosylation of G,-protein a-
subunits was studied. By analogy to dimethyl sulphoxide-
differentiated HL-60 cells (Gierschik et al., 1989), fMLP (10 FM)
enhanced CTX-catalysed ADP-ribosylation of G,-protein a-
subunits in membranes from Bt2cAMP-differentiated HL-60
cells (see Figure 4). Unlike fMLP, Pam3AhhSK4 (10 uM) did not
enhance ADP-ribosylation of G,-protein a-subunits.
We investigated the effects of Pam3AhhSK4 on [Ca2+]1 in
Bt2cAMP-differentiated HL-60 cells. The lipopeptide (0.3-
10 FM) did not induce rises in [Ca2+]1 in HL-60 cells (results not
shown). By contrast, fMLP potently and effectively increases
[Ca2+1] in Bt2cAMP-differentiated HL-60 cells (Seifert et al.,
1992a,b).
The effects of lipopeptides and fMLP on PA formation are
shown in Table 3. Pam3AhhSK4 (10 M) and fMLP (1 FM)
increased PA formation by 23 % and 42% respectively. In PTX-
treated cells, the stimulatory effects of Pam3AhhSK4 and fMLP
on PA formation were greatly diminished. In the presence of
ethanol (0.5 %, v/v), Pam3AhhSK4 (10 FM) and fMLP (1 FM)
stimulated phosphatidylethanol formation to a similar extent as
PA formation (results not shown).
Regulation by lipopeptides of 02- formation in HL-60 cells is
depicted in Figure 5. Pam3AhhSK4 itself up to 100FM did not
activate 02- formation. However, Pam3AhhSK4 potentiated O2
formation induced by fMLP (1 FM) with an EC50 of about 2FM
and a maximum at 10 FM. fMLP activated 02- formation with
an EC50 of 15 nM and a maximum at 100 nM. Pam3AhhSK4
(10 FM) substantially enhanced the effect of fMLP at sub-
maximally and maximally effective concentrations.
DISCUSSION
Lipopeptides activate 02- formation in human neutrophils in a
PTX-sensitive manner, suggesting the involvement ofG1-proteins
in the signal-transduction pathway (Seifert et al., 1990). So far,
however, a heptahelical receptor for lipopeptides has not yet
been identified. In addition, lipopeptides, unlike chemo-
attractants, do not induce rises in [Ca2+], in HL-60 cells(Wenzel-Seifert and Seifert, 1993; Seifert et al., 1992a,b). Thus it
is unlikely that lipopeptides activate Bt2cAMP-differentiated
HL-60 cells through a chemoattractant receptor with known
ligands or through the newly cloned formyl-peptide-related re-
ceptor with as-yet unknown ligands (Murphy et al., 1992).
Therefore we have put forward the hypothesis that lipopeptides
activate G1-proteins directly, i.e. in a receptor-independent
manner (Seifert et al., 1990). This assumption is supported by the
finding that only lipopeptides bearing positive charges activate
02- formation in human neutrophils (Seifert et al., 1990). By
analogy to lipopeptides, the stimulatory effects of various direct
G-protein activators in neutrophils are inhibited, at least in part,
by PTX (Serra et al., 1988; Perianin and Snyderman, 1989;
Seifert et al., 1990, 1992b; Norgauer et al., 1992; Kanaho et al.,
1992). To corroborate our suggestion further, we have now
studied the effects of lipopeptides in Bt2cAMP-differentiated HL-
60 cells, as these cells are a useful model system for the analysis
of Ga-protein-mediated signal-transduction processes at the
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cellular and membrane level (Krautwurst et al., 1992; Seifert et
al., 1992a; Wenzel-Seifert and Seifert, 1993).
We found that the lipopeptide Pam3AhhSK4 activated high-
affinity GTP hydrolysis in HL-60 membranes in a time-,
membrane-protein- and stimulus-concentration-dependent
manner (see Figures 1 and 3). Most importantly, the stimulatory
effects of lipopeptides on GTPase were inhibited by PTX, as were
those offMLP (see Table 1). These data indicate that lipopeptides
increase the GTPase activity of G1-proteins. Pam3AhhSK4
increased Vm.. of GTP hydrolysis, suggesting that it stimulated
the catalytic rate of GTP turnover (see Figure 2). By analogy
with lipopeptides, formyl-peptides also increase VmJ- of GTP
hydrolysis (see Figure 2) (Feltner et al., 1986). The stimulatory
effect of Pam3AhhSK4 on high-affinity GTPase was not
unspecific, inasmuch as the lipopeptide did not affect the activities
of other nucleotide-metabolizing enzymes, i.e. Mg2+-ATPase and
Na+/K+-ATPase, in HL-60 membranes.
NEM, through alkylation of G,-protein a-subunits, disrupts
the interaction of heptahelical receptors with G-proteins in a
manner similar to that of PTX-catalysed ADP-ribosylation
(Jakobs et al., 1982; McLeish et al., 1989). With respect to
the interaction of formyl-peptide receptors with G,-protein
a-subunits, alkylation and ADP-ribosylation have similar
consequences, i.e they are inhibitory (see Tables 1 and 2)
(McLeish et al., 1989). Concerning the interaction oflipopeptides
with G,-proteins, ADP-ribosylation is also inhibitory (see Table
1). Unexpectedly, alkylation was found to enhance the relative
extent of lipopeptide-stimulated GTP hydrolysis (see Table 2).
These data suggest that alkylation and ADP-ribosylation of a-
subunits may affect G-protein function in different manners.
Alkylation of G(-protein a-subunits, unlike ADP-ribosylation,
may increase their lipophilicity, and thereby may facilitate their
interaction with lipophilic portions of lipopeptides. It is also
possible that alkylation and ADP-ribosylation induce different
conformations of G,-protein a-subunits, resulting in opposite
effects concerning their interaction with lipopeptides, but not
with regard to receptors.-Additionally, Pam3AhhSK4 and fMLP
activated GTPase in NEM-treated membranes in a synergistic
manner. Taken together, these results suggest that lipopeptides
and formyl-peptides differently activate the GTPase of G1-
proteins.
Certain lipopeptides, i.e. Pam3CSK4 and Pam3AdhSK4, do not
stimulate GTP hydrolysis in membranes from Bt2cAMP-
differentiated HL-60 cells (Seifert et al., 1992b). It is possible that
the extent of activation of G,-proteins induced by these
lipopeptides is too small to be detected in the GTPase assay.
Pam3CSK4, Pam3AdhSK4 and Pam.AhhSK4 have in common
the positively charged peptide chain, but they differ in the
structure of the lipid moiety (Seifert et al., 1992b). With respect
to GTP hydrolysis, only Pam.AhhSK4 is stimulatory (see Figure
3) (Seifert et al., 1992b). These differential effects of lipopeptides
on GTP hydrolysis support the view that these substances do not
activate the GTPase of G,-proteins in an unspecific manner.
Intriguingly, the results of a recent study indicate that lipophilic
amino acids in the third cytoplasmic loop of heptahelical
receptors may be more important for G-protein activation than
are positively charged amino acids (Cheung et al., 1992). By
analogy, the structure of the lipid moiety of lipopeptides is
important for their G-protein-activating properties (see Figure 3)
(Seifert et al., 1992b). However, the peptide chain is also of
relevance for G-protein activation by lipopeptides. This as-
sumption is supported by the findings that the lipopeptides
Pam3CSK4, Pam3CSK4RPQASGVYMGNLTAQ, Pam8CSK4-
RPQASVYMNLTAQ and Pam3CSK.YGGFL have in common
effectiveness to activate the GTPase of Gi-proteins (see Figure 3)
(Seifert et al., 1992b).
The microbial alkaloid staurosporine is a potent inhibitor of
protein kinases, in particular of protein kinase C (Tamaoki et al.,
1986). In addition, staurosporine stimulates phospholipase D in
rabbit neutrophils, presumably via direct activation of Gi, but it
does not activate phospholipase C (Kanaho et al., 1992). By
analogy, positively charged lipopeptides inhibit protein kinase C
and do not induce rises in [Ca2+]i in HL-60 cells (Bessler, 1990;
Seifert et al., 1992b). These findings prompted us to study
the effects of Pam.AhhSK4 on phospholipase D in HL-60
cells. Pam3AhhSK4 activated the formation of PA and
of phosphatidylethanol, a transphosphatidylation product
specifically formed by phospholipase D (see Table 3) (Pai et al.,
1988; Bourgoin and Grinstein, 1992). Additionally, stimulation
by PamkAhhSK4 of PA formation was PTX-sensitive (see Table
3). These data indicate that the lipopeptide activates
phospholipase D via G,-proteins.
In this context, the question arises whether the effects of
Pam3AhhSK4 on phospholipase D were mediated via Gi2, Gi3
or both Ga-proteins. Therefore we studied the effects of
Pam3AhhSK4 on photolabelling and CTX-catalysed ADP-
ribosylation of G,-protein a-subunits in HL-60 membranes. Both
methods have been shown to be useful for the analysis of G -
protein activation by formyl-peptide receptors in membranes
from dimethyl sulphoxide-differentiated HL-60 cells (Gierschik
et al., 1990; Offermanns et al., 1990). In agreement with the
aforementioned studies, we found prominent stimulatory effects
of fMLP on photolabelling and CTX-catalysed ADP-
ribosylation of Ga-protein a-subunits in membranes from
Bt2cAMP-differentiated HL-60 cells (see Figure 4). However,
Pam3AhhSK4 was devoid of any stimulatory effect in these
regards. Thus we cannot yet answer the question as to which G,-
protein subtypes are involved in the activation of phospholipase
D by lipopeptides. Interestingly, some lipopeptides do not
measurably stimulate the GTPase of G,-proteins (Seifert et al.,
1992b). Moreover, even the most effective lipopeptides with
regard to GTPase activation, i.e. Pam3AhhSK4, Pam3CSK4-
RPQASGVYMGNLTAQ and Pam3CSK4RPQASVYLMNLT-
AQ, are still much less effective than fMLP (see Figure 3). Thus
the sensitivity of photolabelling and CTX-catalysed ADP-ribo-
sylation may be too low to detect the relatively small extent of
Gi-protein activation by Pam3AhhSK4. However, it cannot be
excluded that the lack of stimulatory effect of lipopeptides on
photolabelling and CTX-catalysed ADP-ribosylation reflects also
qualitative differences in activation of G,-proteins by these
substances and by formyl-peptides (McLeish et al., 1989).
The data obtained with Pam3AhhSK4 concerning stimulation
of PA formation imply that an increase in [Ca2+]1 via activation
of phospholipase C and/or non-selective cation channels is not
a prerequisite for stimulation of phospholipase D (see Table 3)
(Seifert et al., 1992b). In agreement therewith, Rosoff et al.
(1988), Bourgoin et al. (1990) and Kanaho et al. (1992) suggested
that phospholipase D is activated in a Ca2+/phospholipase C-
independent manner. However, in human neutrophils, rises in
[Ca2+]1 may play a part in the activation of phospholipase D
(Kessels et al., 1991; Bauldry et al., 1992).
The effectiveness of Pam3AhhSK4 to activate PA formation
was about 50% of that of fMLP (see Table 3). Nonetheless, the
lipopeptide itself did not activate 2- formation (see Figure 5).
Thus stimulation of phospholipase D is not sufficient for the
activation of NADPH oxidase. Our data are in agreement with
those obtained by Kessels et al. (1991) and Bauldry et al. (1992).
By analogy to the cytokines, granulocyte/macrophage-colony-
the lipid portion, but differ in the peptide chain and their stimulating factor and tumouir necrosis factor-a, activation of
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PA formation by lipopeptides may be important for potentiation
of fMLP-induced 02- formation (see Table 3 and Figure 5)
(Bourgoin et al., 1990; Bauldry et al., 1990).
In conclusion, we have shown that lipopeptides activate the
GTPase of G1-proteins and that lipopeptides and fMLP
activate G,-proteins differently. Lipopeptides activate
phospholipase D via G,-proteins, but PA formation is not
sufficient for the activation of 02- formation.
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